Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).
Clinical trial NCT03634826 · UNKNOWN
Trial details
- NCT number
- NCT03634826
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-15
- Primary completion
- 2021-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.